Private Trust Co. NA Acquires 337 Shares of Intuitive Surgical, Inc. $ISRG

Private Trust Co. NA increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.7% during the second quarter, Holdings Channel.com reports. The firm owned 1,760 shares of the medical equipment provider’s stock after buying an additional 337 shares during the period. Private Trust Co. NA’s holdings in Intuitive Surgical were worth $956,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Norway Savings Bank boosted its stake in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares in the last quarter. IronOak Wealth LLC. acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $1,099,000. Trust Co. of Oklahoma acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $363,000. Neville Rodie & Shaw Inc. boosted its stake in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares in the last quarter. Finally, Sax Wealth Advisors LLC boosted its stake in Intuitive Surgical by 218.1% in the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after acquiring an additional 1,684 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last 90 days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 2.6%

NASDAQ ISRG opened at $446.13 on Friday. The company has a fifty day simple moving average of $454.97 and a two-hundred day simple moving average of $495.75. The stock has a market cap of $159.93 billion, a P/E ratio of 62.22, a P/E/G ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter last year, the company posted $1.78 earnings per share. The firm’s revenue was up 21.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Evercore ISI lowered their target price on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. Mizuho lowered their target price on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating for the company in a research note on Tuesday, October 14th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. Truist Financial lowered their target price on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $580.29.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.